About UsA clinical-stage biotechnology company focused on dermatology, wound care, and infectious disease.Read More News Releases Turn Therapeutics Announces New Peer-Reviewed Research Showing GX-03 Selectively Reduces Key Drivers of Skin Inflammation and Itch August 20, 2026 Read More Turn Therapeutics Provides Corporate Updates and Reports Second Quarter 2026 Financial Results August 12, 2026 Read More Turn Therapeutics to Ring the Nasdaq Closing Bell on Monday, August 10, 2026 July 28, 2026 Read More All News Releases
Turn Therapeutics Announces New Peer-Reviewed Research Showing GX-03 Selectively Reduces Key Drivers of Skin Inflammation and Itch August 20, 2026 Read More
Turn Therapeutics Provides Corporate Updates and Reports Second Quarter 2026 Financial Results August 12, 2026 Read More
